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The aim of this retrospective study was to examine the incidence 
and prognostic significance of abdominal wall metastases in pa­
tients with ovarian cancer present at the primary debulking at the 
entry sites of previous laparoscopy or paracentesis. The clinical 
records of 219 patients were studied. In 7 of 43 patients (16%) 
who had undergone laparoscopy and 3 of 30 patients (10%) who 
had undergone paracentesis previous to the primary debulking, 
an abdominal wall metastasis had developed at the entry sites. 
All metastases occurred in patients with FIGO stage IIIC-IV 
including ascites. Survival analysis using the Cox proportional 
hazards model showed that after adjustment for age, FIGO stage3 
histology, grade, ascites, and residual disease after primary de­
bulking, the presence of abdominal wall metastases in the entry 
sites of previous laparoscopy or paracentesis was negatively, al­
though not statistical significantly, correlated with survival (P =
0.14). © 1996 Academic Press, Inc.
INTRODUCTION
Both laparoscopy and paracentesis are known procedures 
in the diagnosis of abdominal malignancy including ovarian 
cancer. Numerous case reports have described the develop­
ment of tumor implants occurring at the abdominal trocar 
entry sites after laparoscopy in patients with ovarian cancer 
[1-5], Nevertheless, some of these reports have stated that 
the development of such tumor implants after laparoscopy 
in patients with ovarian carcinoma is rare [I, 2]. So far, to 
our knowledge, no systematic study has been performed 
regarding its incidence and possible prognostic significance.
This retrospective study was performed to determine the 
incidence of abdominal wall metastases at trocar or puncture 
entry sites after laparoscopy or paracentesis, and whether it 
influences survival.
1 To whom correspondence should be addressed.
MATERIALS AND METHODS
The case records of 419 patients with ovarian cancer diag­
nosed between 1979 and 1991 in the University Hospital 
Nijmegen and the Bosch Medical Center at ’s-Hertogen­
bosch were scrutinized. The year 1979 was chosen because 
from that year onward cisplatin was common as part of the 
adjuvant chemotherapy. Only those patients with epithelial 
ovarian cancer and no previous therapy were included in the 
study (n = 219). They were staged according to the revised 
FIGO classification of 1987 [6]. Patient's age and tumor 
characteristics are summarized in Table 1, Abdominal wall 
metastases at the laparoscopic trocar or paracentesis sites 
had to comply with the following criteria: (1) presence at the 
primary debulking, (2) subcutaneous, and (3) histologically 
confirmed. All abdominal wall metastases were removed 
during the primary debulking. The survival time was calcu­
lated from the date of the primary debulking.
All laparoscopies were performed using the double-punc­
ture technique. After making a (sub)umbilical incision (1 
cm), a Verres needle was inserted and a pneumoperitoneum 
was established by insufflating carbon dioxide to an intraab­
dominal pressure of 10 mm Hg. After removing the Verres 
needle a 10-mm trocar was placed through the (sub)umbilical 
incision. The laparoscope was introduced through this trocar 
and used to transilluminate the site of the second port. This 
second S-mm trocar was introduced at either the midline or 
lower right quadrant of the abdomen. Paracenteses were not 
routinely performed with ultrasonic guidance.
Cox’s proportional hazards’ model was used to quantify 
the effect of the presence of the abdominal wall metastases 
at the entry sites of previous laparoscopy or paracentesis on 
survival, taking account of known prognostic factors (age, 
FIGO stage, histology, grade, residual disease after primary 
debulking, and the presence or absence of ascites). The per­
formance status could not be introduced as a variable with 
possible effect on survival because the performance status
«
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TABLE 1
Age and Tumor Characteristics of the 219 Patients
Number of 
patients (%)
Age (years)
^44 35 (16.0)
45-54 47 (21.5)
55-64 60 (27.4)
65-74 63 (28.7)
^75 14 (6.4)
FIGO stage
I 52 (237)
II 35 (16.0)
III 103 (47.0)
IV 29 (13.3)
Grade
I 22 ( 12.2 )
II 64 (35.4)
III 90 (49.7)
Undifferentiated 5 (2.7)
Unknown 38
Histology
Serous 84 (38.4)
Mucinous 43 (19.6)
Endometrioid 31 (14.2)
Cystadenocarcinoma 39 (17.8)
Clear cell 7 (3.2)
Malignant Brenner 4 (1.8)
Mixed 6 (2.7)
Undifferentiated 5 (2.3)
Ascites
No 105 (48.4)
Yes 112 (51.6)
Unknown 2
Residual disease after primary debulking
None (macroscopic) 74 (40.6)
< 2  cm 46 (25.3)
> 2  cm 62 (34.1)
Unknown 37
Abdominal wall metastases
No previous laparoscopy or paracentesis
No 144 (96.0)
Yes 6  (4 .0 )
Previous laparoscopy or paracentesis
No 57 (82.6)
Yes, at trocar or puncture entry site 10 (14.5)
Yes, not at trocar or puncture entry sites 2 (2.9)
was not systematically registered in the case records. First, 
the likelihood-ratio test (LR test) was applied to investigate 
the influence of each of the above-mentioned factors on 
survival. Second, the effect on survival of abdominal wall 
metastases was evaluated after adjustment for all other fac­
tors. The variable age was divided into five subgroups of 
patients (^44, 45-54, 55-64, 65-74, and 5=75 years). The 
variable histology was reduced to two subgroups (serous/ 
mucinous/endometrioid/not classified cystadenocarcinoma 
and clear cell/malignant Brenner/mixed/undifferentiated).
The variable residual disease after primary debulking was 
divided into three types (no macroscopic residual disease, 
residual disease ^2  cm, and residual disease >2 cm). The 
variable abdominal wall metastases was divided into three 
types (no abdominal wall metastases, abdominal wall métas­
tasés not related to entry sites of previous laparoscopy or 
paracentesis, and abdominal wall metastases at entry sites 
of previous laparoscopy or paracentesis). The amount of 
fluid that constitutes ascites was defined as 100 ml or more.
RESULTS
»
in 7 of 43 patients (16%) in whom a diagnostic laparos­
copy was performed preceding the primary debulking, one 
or more abdominal wall metastases developed at the entry 
sites (five patients had a metastasis at one, two patients had 
metastases at two entry sites). In 3 of 30 patients (10%) in 
whom one (n — 25) or more (n = 5) paracenteses were 
performed preceding the primary debulking, an abdominal 
wall metastasis developed at the entry site. In these three 
patients only one paracentesis was performed. In none of 
the laparoscopic procedures and paracenteses were difficul­
ties and/or complications reported. All 10 patients with ab­
dominal wall metastases at the entry sites of the laparoscopic 
trocars or paracentesis had the following features in com­
mon: FIGO stage IIIC or IV; grade II, III, or “ unknown” ; 
and ascites present at the primary debulking. None of the 
women without ascites (n — 21) and/or stage I-II disease 
(n = 14) developed abdominal wall metastases following 
laparoscopy or paracentesis. The median time interval be­
tween the laparoscopy or paracentesis and primary debulking 
was 15 days in the 10 patients who had developed abdominal 
wall metastases at the trocar entry sites (range, 9-35 days) 
and 13 days in the 63 patients who had not developed abdom­
inal wall metastases after previous laparoscopy or paracente­
sis (range, 1-187 days); the difference was not statistically 
significant.
Eight patients had abdominal, wall metastases present at 
the primary debulking not related to a previous laparoscopy 
or paracentesis (Table 1).
The survival time was significantly related to age, FIGO 
stage, tumor grade, residual disease after primary debulking, 
ascites, and abdominal wall metastases at the entry sites of 
previous laparoscopy or paracentesis (Table 2). No signifi­
cant correlation was found with tumor histology. In the Cox 
proportional hazards’ model, patients with abdominal wall 
metastases at the entry sites adjusted for age, FIGO stage, 
grade, histology, ascites, and residual disease after primary 
debulking had a shorter survival time, although the differ­
ence was not statistically significant (Table 3). For example, 
patients with abdominal wall metastases at the entry sites 
of previous laparoscopy or paracentesis together with the 
combination of age of 65-74 years, grade III cystadenocarci-
TABLE 2
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Relation between Factors and Survival among 219 Ovarian Cancer Patients, Diagnosed between 1979 and 1991
Factor
Number of 
patients
Number of 
deaths in 3 
years (% )a
Relative 
hazard with 
respect to 
baseline
95% 
confidence 
interval for 
relative hazard P value
Age group
VI 35 6 (17) L 00 Baseline < 0.001
45-54 47 18 (38) 2.02 0.96- 4.26
55-64 60 29 (48) 2.56 1.26- 5.19
65-74 63 35 (56) 3.56 1.79- 7.10
2:75 Í4 1 1 (79) 9.70 4.07-23.13
FIGO stage
I 52 5 (10) 1.00 Baseline < 0.001
II 35 5 (14) 1.68 0.67- 4.26
III 103 65 (63) 9.19 4.55-18.57
IV 29 24 (83) 23.63 10.64-52.48
Grade
I 22 3 (14) 1.00 Baseline < 0.001
II 64 24 (38) 3.12 1.2 2 - 7.98
III + undifferentiated 95 55 (58) 5.27 2 .11-13.17
Histology
Cystadenocarcinoma 197 86 (44) 1.00 Baseline 0.70
Others 22 13 (59) 1.12 0.63- 1.99
Ascites
No 105 25 (24) 1.00 Baseline < 0.001
Yes 112 74 (66 ) 4.31 2.88- 6.46
Residual disease after debuiking
None (macroscopic) 74 10 (14) 1.00 Baseline < 0.001
^ 2  cm 46 29 (63) 5.72 3.17-10.30
> 2  cm 62 45 (73) 8.23 4.70-14.41
Abdominal wall metastases
No 201 85 (42) LOO Baseline < 0.001
Yes, not at entry sites 8 5 (63) 2.39 1.05- 5.48
Yes, at entry site 10 9 (90) 5.12 2.65- 9.89
All of the deaths were due to cancer progression.
noma FIGO stage III, residual disease > 2  cm, and ascites 
present had a much worse survival than patients with the 
same combination but without abdominal wall métastasés in 
the entry sites (Table 4).
DISCUSSION
Laparoscopy is a common procedure in the diagnostic 
workup of possibly gynecological related complaints. Also
TABLE 3
Relation between Abdominal Wall Metastases and Survival after Adjustment for the Known Risk Factors: Age,
FIGO Stage, Tumor Grade, Histology, Ascites, and Residual Disease
Number of 
patients
Number of 
deaths in 3 
years (%)a Risk Ratio
95% confidence 
interval P value
Abdominal wall metastases 
No 137 63 (46) 1.00 Baseline 0.14
Yes, not at entry sites 6 4(67) 1.10 0.38-3.22
Yest at entry site 7 6 (86) 2.70 1.08-6.75
Unknown for at least one factor 69
" All of the deaths were due to cancer progression.
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TABLE 4
Survival (Calculated within the Cox’s Proportional Hazards’ Model. All Patients 65-74 Years of Age, FIGO III,
Cystadenocarcinoma, Tumor Grade III, Residual Disease >2 cm, and Ascites Present)
Survival period 
in months
No abdominal wall 
metastases (%)
Abdominal wall 
metastases outside 
trocar or puncture 
entry sites (%)
Abdominal wall 
metastases at 
trocar or puncture 
entry site (%)
3 92 91 79
6 85 84 65
12 64 61 30
18 46 42 12
24 31 28 4
in cases in which an ovarian malignancy is suspected, a 
laparoscopy can be performed to confirm the diagnosis. In 
the presence of ascites a paracentesis with cytological exami­
nation of the fluid obtained can attribute to the diagnosis. 
Numerous case reports have mentioned the development of 
tumor metastases at entry sites after a diagnostic laparoscopy 
in patients with ovarian cancer. In reports on patients with 
advanced disease [1, 2], and also in patients with ovarian 
tumors of low malignant potential [3, 5], metastases in the 
abdominal wall after a diagnostic laparoscopy have been 
described. Childers et a l [7] recently reviewed 88 diagnostic 
laparoscopic procedures in which an intraperitoneal malig­
nancy was documented, of which 88% (77/88) had gross 
disease and 80% (70/88) had ovarian cancer. In only one 
case, in which microscopical ovarian cancer disease was 
present, a tumor metastasis developed at the abdominal wall 
puncture site. It was stated therefore that such tumor implan­
tation after laparoscopy is an infrequent occurrence.
In the present study, in 43 of 219 patients (19.7%) a 
diagnostic laparoscopy preceded the primary debulking of 
an ovarian carcinoma. Furthermore, in 30 patients (13.7%) 
a paracentesis was performed preceding the primary debulk­
ing. In 10 of these 73 patients (13.7%) abdominal wall tumor 
implantation occurred at these trocar or puncture sites. This 
is a much higher percentage than that reported by Childers 
et a l [7]. The reason(s) for this discrepancy is not known. 
The occurrence of abdominal wall metastases after laparos­
copy or paracentesis was reportedly only in patients with 
FIGO stage IIIC - IV  including the presence of ascites. None 
of the women without ascites and/or stage I —II disease ab­
dominal wall metastases developed in the interval between 
laparoscopy or paracentesis and laparotomy. Nduka et a l
[8], in a review, mentions numerous aspects specifically re­
lated to laparoscopy which may lead to an increased likeli­
hood of wound metastases. The present data support the 
concept that the presence and possibly leakage of ascites 
through the small skin incision is one of the mechanisms 
resulting in an increased contamination of these skin inci­
sions with malignant cells.
A negative correlation was found between the develop­
ment of these metastases and duration of survival indepen­
dent of known prognostic factors such as age, FIGO stage, 
grade, histology, residual disease after primary debulking, 
and the presence or absence of ascites. This negative correla­
tion was not statistically significant, possibly due to the small 
samples. It is plausible that in cases of stage III—IV ovarian 
carcinoma, the development of abdominal wall metastases 
at the entry sites after laparoscopy or paracenteses itself does 
not affect survival, but rather it is the expression of the 
biological aggressiveness of the tumor which in turn explains 
the shorter survival.
In addition to diagnostic laparoscopic procedures, laparo­
scopic surgery is becoming more widely used in the treat­
ment of adnexal masses considered as being benign. Maiman 
et a l [9] found that 31 % of laparoscopically removed ovar­
ian tumors considered to be benign were subsequently found 
to be malignant. Recently, the development of an abdominal 
wall metastasis after laparoscopic removal of a borderline 
ovarian tumor has been described [10]. Therefore, it is im­
portant that also in cases in which an ovarian tumor is consid­
ered to be benign and is laparoscopically removed, one 
should try to minimize the exposure of the small incisions 
to exfoliated cells [8]. This can be accomplished by leaving 
the ovarian tumor intact until it is resected and placed in a 
pouch in which it can be aspirated if necessary and finally 
removed through the skin incision.
In conclusion, in cases of pelvic masses in which an ovar­
ian malignancy is supected, one should be reserved in per­
forming a laparoscopy or paracentesis. The development of 
abdominal wall metastases in these cases at the entry sites 
of previous laparoscopy or paracentesis is a grave prognostic 
sign. During laparoscopic surgery one should always try to 
minimize the exposure of the small skin incisions to exfoli­
ated cells.
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